Axsome Therapeutics Inc
WKN: A2AA7B / ISIN: US05464T1043Axsome Therapeutics, Inc. (AXSM)
| eröffnet am: | 30.10.17 10:15 von: | Chalifmann3 |
| neuester Beitrag: | 25.04.21 00:07 von: | Melaniebqaua |
| Anzahl Beiträge: | 3 | |
| Leser gesamt: | 6219 | |
| davon Heute: | 1 | |
bewertet mit 0 Sternen |
||
|
|
||
30.10.17 10:16
#2
Chalifmann3
hier
https://de.finance.yahoo.com/quote/AXSM/profile?p=AXSM
Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The companys product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and Alzheimers disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain. The company was founded in 2012 and is based in New York, New York.
Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The companys product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and Alzheimers disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain. The company was founded in 2012 and is based in New York, New York.
09.03.20 13:14
#3
Chalifmann3
hi
hi leute,schaut mal was ich hier ausgegraben hab,bin leider nicht dabei .......
MFG
Chali
MFG
Chali